Jeremy M. Levin - 23 Mar 2026 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Reporting relationship: Executive Chairman, Director
Issuer ticker: OVID
Reported as of: 23 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Mar 2026, 21:18:27 UTC
Prior SEC filing: 02 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeremy Levin

Key filing fact

Jeremy M. Levin filed Form 4 for Ovid Therapeutics Inc. (OVID) on 25 Mar 2026.

Key facts

This page summarizes Jeremy M. Levin's Form 4 filing for Ovid Therapeutics Inc. (OVID).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Mar 2026, 21:18.

Change

Previous filing in this sequence was filed on 02 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001256153 Primary reporting owner

LEVIN JEREMY M

Relationship: Executive Chairman, Director
Address: C/O OVID THERAPEUTICS INC., 441 NINTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Jeremy Levin
Signature date: 25 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OVID transaction

Common Stock

Options Exercise

Transaction value
Shares: +47,333
Change %: +1.3%
Price: $1.40^*
Shares after: 3,735,048
Date: 23 Mar 2026
Ownership: Direct

OVID holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,461
Date: 23 Mar 2026
Ownership: See Footnote
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OVID transaction Derivative

Series A Warrant (right to buy)

Options Exercise

Transaction value
Shares: -47,333
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 23 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 47,333
Exercise price: $1.40
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse is the manager of Divo. The Reporting Person disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.

Footnote F2

Each Series A Warrant became immediately exercisable pursuant to the approval of the Issuer's Stockholders on December 11, 2025.